Denosumab treatment in postmenopausal women with osteoporosis - Authors' reply. [electronic resource]
- The lancet. Diabetes & endocrinology 10 2017
- 768-769 p. digital
Publication Type: Letter; Comment
2213-8595
10.1016/S2213-8587(17)30288-7 doi
Antibodies, Monoclonal Bone Density Bone Density Conservation Agents Denosumab Female Humans Osteoporosis Osteoporosis, Postmenopausal Postmenopause